CN Stock MarketDetailed Quotes
000590 Tus-Pharmaceutical Group
- 6.50
- +0.46+7.62%
Market Closed Sep 30 15:00 CST
1.56BMarket Cap-342105P/E (TTM)
6.57High5.94Low154.60KlotVolume6.30Open6.04Pre Close97.77MTurnover6.46%Turnover Ratio61.90P/E (Static)239.47MShares11.2552wk High2.22P/B1.56BFloat Cap4.8052wk Low6.64Limit Up239.38MShs Float35.83Historical High5.44Limit Down10.43%Amplitude1.68Historical Low--Dividend TTM6.32Avg Price76.24KlotAsk--Div YieldTTM100Lot Size75.01KlotBid
Tus-Pharmaceutical Group Key Stats
EPS
According to the latest financial report of Tus-Pharmaceutical Group, the latest earnings per share (TTM) for the company is -0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Tus-Pharmaceutical Group's latest financial report to see how much their book value per share (BVPS) is currently at 2.92.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Tus-Pharmaceutical Group shows that the company's current ratio is 2.09, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Tus-Pharmaceutical Group, the quick ratio is 1.49, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Tus-Pharmaceutical Group? The latest ROE figure is -3.29%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Tus-Pharmaceutical Group, the total asset return on investment (ROA) is -2.04%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Tus-Pharmaceutical Group's latest financial report to see how their gross margin is doing - currently at 47.31%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Tus-Pharmaceutical Group, the net profit margin is -15.87%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data